Nobuhiko Seki, Kei Morikawa, Tomonori Makiguchi, Shigeru Tanzawa, Tetsuo Shimizu, Saori Takata, Katsuhiko Naoki, Yuichiro Takeda, Tamotsu Ishizuka, Yuko Oya, Tadashi Kohyama, Kyoichi Kaira, Kazuma Kishi, Satoshi Watanabe, Takafumi Suda, Hiromichi Yamane, Masashi Ishihara, Hiroshi Kagamu, Kenichi Yoshimura, Noriyuki Matsutani. "Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with
            <i>EGFR</i>
            mutations: Heat on Beat randomized phase II study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8633